Table 1.
Dosages and dose regimen of anti-inflammatory and immunosuppressive agents used in the 13-week mechanistic study
Group | Name | Concentration | Dose | Dose Volume | Route | Dosing Days |
---|---|---|---|---|---|---|
3 | Prednisolone (10 mg as tablets)a | 1 mg/mL | 1 mg/kg/day | 1 mL/kg | Oral (gavage) | Day −1 to 29, and then day 31, 33, 35, 37, 39, and 41 |
4 | Rituximabb | 10 mg/mL | 20 mg/kg | 2 mL/kg | Intravenous | Every 2 weeks (day −14, day −1, 14, 28, 42, 56, 70, and 84) |
4 | Everolimus (2.5 mg as tablets)a | 0.5 mg/mL | 0.5 mg/kg/day | 1 mL/kg | Oral (gavage) | Daily, week −2 until end of the dosing phase (day 14) |
As these are tablets, they were dissolved in normal drinking water and administered orally by gavage after a visual check for correct dissolution.
Diphenhydramine is an antihistamine, which has been administered intramuscularly as a premedication 30–60 min before rituximab administration at a concentration of 50 mg/mL, a dose of 4 mg/kg, and a volume of 0.08 mL/kg.